AU2000276362A1 - Composition for the treatment of diabetes - Google Patents
Composition for the treatment of diabetesInfo
- Publication number
- AU2000276362A1 AU2000276362A1 AU2000276362A AU7636200A AU2000276362A1 AU 2000276362 A1 AU2000276362 A1 AU 2000276362A1 AU 2000276362 A AU2000276362 A AU 2000276362A AU 7636200 A AU7636200 A AU 7636200A AU 2000276362 A1 AU2000276362 A1 AU 2000276362A1
- Authority
- AU
- Australia
- Prior art keywords
- diabetes
- treatment
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/608,272 US6291495B1 (en) | 1997-02-24 | 2000-06-30 | Method and composition for the treatment of diabetes |
US09608272 | 2000-06-30 | ||
PCT/CA2000/001152 WO2002004024A1 (en) | 2000-06-30 | 2000-09-29 | Composition for the treatment of diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2000276362A1 true AU2000276362A1 (en) | 2002-01-21 |
Family
ID=24435759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2000276362A Abandoned AU2000276362A1 (en) | 2000-06-30 | 2000-09-29 | Composition for the treatment of diabetes |
Country Status (3)
Country | Link |
---|---|
US (1) | US6291495B1 (en) |
AU (1) | AU2000276362A1 (en) |
WO (1) | WO2002004024A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020004515A1 (en) * | 1997-06-18 | 2002-01-10 | Smith Stephen Alistair | Treatment of diabetes with thiazolidinedione and metformin |
US20020028768A1 (en) * | 1997-06-18 | 2002-03-07 | Smithkline Beecham P.L.C. | Treatment of diabetes with rosiglitazone and insulin |
US20010049380A1 (en) * | 1997-06-18 | 2001-12-06 | Smith Stephen Alistair | Treatment of diabetes with thiazolidinedione and sulphonylurea |
SI0996444T1 (en) * | 1997-06-18 | 2007-08-31 | Smithkline Beecham Plc | Treatment of diabetes with thiazolidinedione and metformin |
US20020016287A1 (en) * | 1997-07-18 | 2002-02-07 | Smithkline Beecham P.L.C. | Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide |
US6376549B1 (en) * | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
CA2344246A1 (en) * | 1998-09-17 | 2000-03-23 | Akesis Pharmaceuticals, Inc. | Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
KR200249057Y1 (en) * | 2001-03-22 | 2001-10-19 | 김진환 | Sewage backflow integrated into the lid and base. Odor Prevention Device |
PL205826B1 (en) * | 2001-07-17 | 2010-05-31 | N Gene Res Lab Inc | A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
MXPA04010392A (en) * | 2002-04-23 | 2005-08-18 | Nutrition 21 Inc | Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance. |
US20060286168A1 (en) * | 2002-07-11 | 2006-12-21 | Masahiko Koike | Process for producing coated preparation |
US8084058B2 (en) * | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US7959946B2 (en) | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US7785627B2 (en) * | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US9060941B2 (en) * | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
UA80991C2 (en) * | 2002-10-07 | 2007-11-26 | Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes | |
US20040091544A1 (en) * | 2002-11-08 | 2004-05-13 | Ruff Michael D. | Coated dibasic calcium phosphate |
US7976853B2 (en) | 2003-01-29 | 2011-07-12 | Takeda Pharmaceutical Company Limited | Process for producing coated preparation |
ZA200602056B (en) | 2003-10-31 | 2007-05-30 | Takeda Pharmaceutical | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
EP1851202A1 (en) * | 2005-02-25 | 2007-11-07 | Takeda Pharmaceutical Company Limited | Pyridyl acetic acid compounds |
PL3050568T3 (en) | 2007-03-13 | 2021-06-14 | Jds Therapeutics, Llc | Methods and compositions for the sustained release of chromium |
WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
US8933022B2 (en) * | 2011-03-01 | 2015-01-13 | Jds Therapeutics, Llc | Methods and compositions for the treatment and prevention Hypoglycemia and related disorders |
WO2014031745A2 (en) * | 2012-08-21 | 2014-02-27 | Nayer Ali | Materials and methods for modulating glucose uptake |
US11865121B2 (en) | 2016-02-11 | 2024-01-09 | Nutrition21, LLC | Chromium containing compositions for improving health and fitness |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3320583A1 (en) | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | NEW GALENIC PREPARATION FORMS OF ORAL ANTIDIABETICS AND METHOD FOR THE PRODUCTION THEREOF |
US4849405A (en) | 1984-05-09 | 1989-07-18 | Synthetic Blood Corporation | Oral insulin and a method of making the same |
US4963526A (en) | 1984-05-09 | 1990-10-16 | Synthetic Blood Corporation | Oral insulin and a method of making the same |
US5206219A (en) | 1991-11-25 | 1993-04-27 | Applied Analytical Industries, Inc. | Oral compositions of proteinaceous medicaments |
US5422125A (en) | 1993-07-12 | 1995-06-06 | Baker Norton Pharmaceuticals, Inc. | Method and composition for treatment of insulin resistance syndromes |
TW438587B (en) | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
US5595763A (en) | 1995-07-19 | 1997-01-21 | Quimica Farmaceutica Bayer S.A. | Tungsten (VI) compositions for the oral treatment of diabetes mellitus |
IT1276130B1 (en) | 1995-11-14 | 1997-10-27 | Gentili Ist Spa | GLIBENCLAMIDE-METFORMIN ASSOCIATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND THEIR USE IN THE TREATMENT OF TYPE DIABETES MELLITUS |
US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
US6153632A (en) * | 1997-02-24 | 2000-11-28 | Rieveley; Robert B. | Method and composition for the treatment of diabetes |
GB9712866D0 (en) * | 1997-06-18 | 1997-08-20 | Smithkline Beecham Plc | Novel method of treatment |
ATE261935T1 (en) | 1997-12-08 | 2004-04-15 | Bristol Myers Squibb Co | NEW METFORMIN SALTS AND METHODS |
CA2344246A1 (en) * | 1998-09-17 | 2000-03-23 | Akesis Pharmaceuticals, Inc. | Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
-
2000
- 2000-06-30 US US09/608,272 patent/US6291495B1/en not_active Expired - Fee Related
- 2000-09-29 AU AU2000276362A patent/AU2000276362A1/en not_active Abandoned
- 2000-09-29 WO PCT/CA2000/001152 patent/WO2002004024A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002004024A1 (en) | 2002-01-17 |
US6291495B1 (en) | 2001-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2000276362A1 (en) | Composition for the treatment of diabetes | |
AU2001272849A1 (en) | Composition for the treatment of osteoarthritis | |
AU2001292480A1 (en) | Novel pyridazine compounds for the treatment of diabetes | |
AU2935200A (en) | Compounds for the treatment of obesity | |
AU2001231104A1 (en) | Methods for treating diabetes | |
AU2001233081A1 (en) | Composition for treatment of stress | |
AU2001272852A1 (en) | Composition for the treatment of migraine | |
AU2002359500A1 (en) | Fabric treatment composition | |
AU2002258221A1 (en) | Medicinal composition | |
AU2000258650A1 (en) | 2-piperidone compounds for the treatment of cancer | |
AU2002240359A1 (en) | Pharmaceutical composition for the treatment of alopecia | |
HUP0401612A3 (en) | Pharmaceutical composition suitable for treating diabetes | |
AU2002241114A1 (en) | Composition | |
AU2001274877A1 (en) | Pest treatment composition | |
AU2001294673A1 (en) | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AU2002327440A1 (en) | Treatment of type i diabetes | |
AU2002255354A1 (en) | Minoxidil-containing liquid composition | |
AU2002365621A1 (en) | Composition for treating the surface of the skin | |
AU2002354460A1 (en) | Medicinal composition | |
AU2002349788A1 (en) | Fiber treatment agent composition | |
AU2683500A (en) | Compositions for the treatment of pain | |
AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
AU5416500A (en) | Pharmaceutical composition for the treatment of calcification | |
EP1177789A3 (en) | Use of phytanic acid for the treatment of diabetes |